Maverick Capital’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-2,057
| Closed | -$970K | – | 451 |
|
|
2023
Q4 | $970K | Buy |
+2,057
| New | +$951K | 0.02% | 127 |
|
|
2023
Q3 | – | Sell |
-1,889
| Closed | -$839K | – | 373 |
|
|
2023
Q2 | $839K | Buy |
+1,889
| New | +$871K | 0.02% | 176 |
|
|
2023
Q1 | – | Sell |
-508
| Closed | -$261K | – | 484 |
|
|
2022
Q4 | $261K | Sell |
508
-36
| -7% | -$18.3K | 0.01% | 323 |
|
|
2022
Q3 | $247K | Buy |
+544
| New | +$260K | 0.01% | 273 |
|
|
2022
Q2 | – | Sell |
-3,729
| Closed | -$1.83M | – | 233 |
|
|
2022
Q1 | $1.83M | Buy |
3,729
+3,217
| +628% | +$1.47M | 0.03% | 111 |
|
|
2021
Q4 | $237K | Sell |
512
-89
| -15% | -$37.4K | ﹤0.01% | 89 |
|
|
2021
Q3 | $224K | Sell |
601
-5,468
| -90% | -$2.08M | ﹤0.01% | 523 |
|
|
2021
Q2 | $2.32M | Buy |
6,069
+5,878
| +3,077% | +$2.25M | 0.02% | 155 |
|
|
2021
Q1 | $69K | Buy |
191
+71
| +59% | +$22.8K | ﹤0.01% | 621 |
|
|
2020
Q4 | $39K | Sell |
120
-10,934
| -99% | -$3.36M | ﹤0.01% | 630 |
|
|
2020
Q3 | $2.97M | Buy |
11,054
+2,691
| +32% | +$724K | 0.06% | 96 |
|
|
2020
Q2 | $2.2M | Sell |
8,363
-7,030
| -46% | -$1.88M | 0.05% | 159 |
|
|
2020
Q1 | $3.5M | Buy |
+15,393
| New | +$4.19M | 0.07% | 122 |
|
|
2019
Q2 | – | Sell |
-724,153
| Closed | -$208M | – | 301 |
|
|
2019
Q1 | $208M | Sell |
724,153
-169,596
| -19% | -$49M | 2.76% | 10 |
|
|
2018
Q4 | $235M | Sell |
893,749
-150,413
| -14% | -$41.4M | 3.45% | 6 |
|
|
2018
Q3 | $286M | Buy |
1,044,162
+1,011,112
| +3,059% | +$262M | 3.56% | 7 |
|
|
2018
Q2 | $7.87M | Sell |
33,050
-6,380
| -16% | -$1.48M | 0.09% | 112 |
|
|
2018
Q1 | $8.66M | Buy |
39,430
+10,230
| +35% | +$2.4M | 0.11% | 124 |
|
|
2017
Q4 | $6.57M | Buy |
29,200
+10,560
| +57% | +$2.25M | 0.08% | 115 |
|
|
2017
Q3 | $3.54M | Buy |
18,640
+5,810
| +45% | +$1.11M | 0.04% | 117 |
|
|
2017
Q2 | $2.41M | Buy |
12,830
+4,540
| +55% | +$816K | 0.03% | 120 |
|
|
2017
Q1 | $1.37M | Sell |
8,290
-240
| -3% | -$38.2K | 0.02% | 104 |
|
|
2016
Q4 | $1.23M | Sell |
8,530
-950
| -10% | -$127K | 0.02% | 96 |
|
|
2016
Q3 | $1.19M | Buy |
9,480
+180
| +2% | +$23.2K | 0.01% | 104 |
|
|
2016
Q2 | $1.22M | Buy |
9,300
+870
| +10% | +$119K | 0.02% | 103 |
|
|
2016
Q1 | $1.17M | Buy |
8,430
+2,690
| +47% | +$359K | 0.02% | 91 |
|
|
2015
Q4 | $800K | Buy |
5,740
+890
| +18% | +$123K | 0.01% | 83 |
|
|
2015
Q3 | $679K | Buy |
+4,850
| New | +$729K | 0.01% | 72 |
|
Other funds holding ELV
Maverick Capital's ELV Position: Q1 2024 in Review
Maverick Capital sold out of Elevance Health (ELV) in Q1 2024, closing a stake of 2,057 shares — an estimated $970K sold.
Maverick Capital first reported a position in ELV in Q3 2015 and held it in 28 quarters. The position peaked at $286M in Q3 2018. 1,666 funds tracked by Wall St. Rank hold ELV as of Q1 2024.
- Maverick Capital reported no remaining Elevance Health position as of Q1 2024 after selling out during the quarter.
- Maverick Capital sold 2,057 Elevance Health shares in Q1 2024, an estimated $970K.
- Maverick Capital first reported a position in Elevance Health in Q3 2015 and held it in 28 quarters.
- Maverick Capital's Elevance Health position peaked at $286M in Q3 2018.
- 1,666 funds tracked by Wall St. Rank held Elevance Health as of Q1 2024.
Based on Maverick Capital's 13F filing for Q1 2024, filed 15 May 2024.